Search
ESSA Pharma Inc
EPIXAdd to Watchlist
0.201USD
0.0000.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
8.93MMarket Cap
LossP/E TTM
More Details of ESSA Pharma Inc Company
ESSA Pharma Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is focused on developing proprietary therapies for the treatment of patients with prostate cancer. Its lead candidate, Masofaniten (formerly EPI-7386), is an oral, small molecule that inhibits the N-terminal domain of the androgen receptor (AR). Masofaniten is in development in combination with antiandrogen treatments in patients with prostate cancer who are earlier in their course of the disease. The Company is completing the clinical development of masofaniten as a monotherapy treatment for patients with metastatic castration-resistant prostate cancer (mCRPC).
ESSA Pharma Inc Info
Ticker SymbolEPIX
Company nameESSA Pharma Inc
IPO dateFeb 22, 2021
CEODr. David Ross Parkinson, M.D.
Number of employees35
Security typeOrdinary Share
Fiscal year-endFeb 22
Address999 West Broadway, Suite 720
CityVANCOUVER
Stock exchangeNASDAQ Capital Market Consolidated
CountryCanada
Postal codeV5Z 1K5
Phone17783310962
Websitehttps://www.essapharma.com/
Ticker SymbolEPIX
IPO dateFeb 22, 2021
CEODr. David Ross Parkinson, M.D.
Company Executives of ESSA Pharma Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Jon Adkins
Mr. Jon Adkins
President, Treasurer, Secretary, Director
President, Treasurer, Secretary, Director
--
--
Mr. David Sidney Wood, CPA
Mr. David Sidney Wood, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Peter Virsik
Mr. Peter Virsik
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
--
-100.00%
Dr. Alessandra Cesano, M.D., Ph.D.
Dr. Alessandra Cesano, M.D., Ph.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
--
-100.00%
Name
Name/Position
Position
Shareholding
Change
Mr. Jon Adkins
Mr. Jon Adkins
President, Treasurer, Secretary, Director
President, Treasurer, Secretary, Director
--
--
Mr. David Sidney Wood, CPA
Mr. David Sidney Wood, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Peter Virsik
Mr. Peter Virsik
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
--
-100.00%
Dr. Alessandra Cesano, M.D., Ph.D.
Dr. Alessandra Cesano, M.D., Ph.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
--
-100.00%
FAQs
Who are the top five shareholders of ESSA Pharma Inc?
The top five shareholders of ESSA Pharma Inc are: Mr. Jon Adkins
How many institutions hold shares of ESSA Pharma Inc (EPIX)?
As of 2025Q3, 79 institutions hold shares of ESSA Pharma Inc, with a combined market value of approximately 34.87M, accounting for 73.70% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -13442442.00.